Zerbaxa Approved for Hospital-Acquired Bacterial Pneumonia

Alternative Medicine Drug Resistance News

TUESDAY, June 11, 2019 — Zerbaxa (ceftolozane and tazobactam) has been approved for a new indication to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia (HABP/VABP) in patients aged 18 years and older, the…

Leave a Reply

Your email address will not be published. Required fields are marked *